Literature DB >> 15504167

Paired comparison of Gambro Trima Accel versus Baxter Amicus single-needle plateletpheresis.

Edwin A Burgstaler1, Jeffrey L Winters, Alvaro A Pineda.   

Abstract

BACKGROUND: Gambro BCT recently introduced the Trima Accel Version 5 (TR) plateletpheresis machine. Platelet (PLT) yields, collection efficiencies (CEs), numbers of white blood cells (WBCs), and processing times of the TR versus the Amicus (Version 2.51) single-needle (AM) procedures were evaluated by use of a prospective paired comparison. STUDY DESIGN AND METHODS: Target yields of 3.0 x 10(11) to 6.8 x 10(11) PLTs in up to 100 minutes of processing time were used. To detect a difference of 1.0 x 10(11) PLTs with a power of 80 percent, 26 paired comparisons were needed.
RESULTS: The mean amount of whole blood processed was significantly higher for TR than for AM (3795 vs. 3520 mL). The TR and AM were equivalent in regard to mean preprocedure PLT count (259 x 10(9) vs. 251 x 10(9)/L), PLT yields (6.7 x 10(11) vs. 6.5 x 10(11)), split rate (65% vs. 65%), processing time (73 vs. 78 min), and collection rate (0.090 x 10(11) vs. 0.084 x 10(11) PLTs/min). The TR had a significantly lower CE than the AM (76% vs. 86%). All of the products (after splitting) had fewer than 5 x 10(6) WBCs.
CONCLUSIONS: The Trima Accel machine processed significantly more whole blood with equivalent PLT yields, processing time, and number of PLTs per minute compared to the Amicus single-needle procedure, but had a significantly lower CE.

Mesh:

Substances:

Year:  2004        PMID: 15504167     DOI: 10.1111/j.0041-1132.2004.04129.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

1.  Analysis of Donor Safety in High Yield Plateletpheresis Procedures: An Experience from Tertiary Care Hospital in South India.

Authors:  Vijay Kumawat; Manu Goyal; Palniappan Marimuthu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-02-27       Impact factor: 0.900

2.  Monitoring of platelet activation in platelet concentrates using transmission electron microscopy.

Authors:  Josef Neumüller; Claudia Meisslitzer-Ruppitsch; Adolf Ellinger; Margit Pavelka; Christof Jungbauer; Renate Renz; Gerda Leitner; Thomas Wagner
Journal:  Transfus Med Hemother       Date:  2013-03-14       Impact factor: 3.747

3.  Single-donor platelet apheresis: observational comparison of the new Haemonetics Universal Platelet protocol with the previous Concentrated Single Donor Platelet protocol.

Authors:  Ugo Salvadori; Cosetta Minelli; Bianca Graziotin; Ivo Gentilini
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

4.  Platelet Recruitment during Multiple Donor Platelet Apheresis Differs between Cell Separators.

Authors:  Stefano Fontana; Peter Keller; Behrouz Mansouri Taleghani
Journal:  Transfus Med Hemother       Date:  2011-05-11       Impact factor: 3.747

5.  A Study on Influence of Donor Hematocrit on the Procedural Parameters of Concentrated Single Donor Platelets Collected by Two Apheresis Devices.

Authors:  Gayathiri K Chellaiya; M Murugesan; Sangeetha K Nayanar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-07-27       Impact factor: 0.900

6.  Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments.

Authors:  Sudipta Sekhar Das; Subrata Sen; R U Zaman; Rathindra Nath Biswas
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-16       Impact factor: 0.900

7.  Initial values of donor hematocrit and efficiency of plateletpheresis.

Authors:  Elvedin Landzo; Alma Sofo-Hafizovic; Vesna Cetkovic-Basic
Journal:  Acta Inform Med       Date:  2013

8.  A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.

Authors:  Kim Anh Nguyen; Hind Hamzeh-Cognasse; Marc Sebban; Elisa Fromont; Patricia Chavarin; Lena Absi; Bruno Pozzetto; Fabrice Cognasse; Olivier Garraud
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.